ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 56 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $320 | -100.0% | 8,984 | -61.1% | 0.02% | -87.1% |
| Q2 2021 | $1,912,000 | -2.7% | 23,086 | -9.9% | 0.19% | -12.3% |
| Q4 2020 | $1,966,000 | +614.9% | 25,626 | +162.7% | 0.21% | +909.5% |
| Q3 2019 | $275,000 | +39.6% | 9,756 | -9.1% | 0.02% | +90.9% |
| Q1 2019 | $197,000 | +60.2% | 10,735 | -37.3% | 0.01% | +57.1% |
| Q1 2018 | $123,000 | +57.7% | 17,116 | -5.0% | 0.01% | +75.0% |
| Q3 2017 | $78,000 | – | 18,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |